[go: up one dir, main page]

ES430416A1 - N-substituted prostaglandin carboxamides - Google Patents

N-substituted prostaglandin carboxamides

Info

Publication number
ES430416A1
ES430416A1 ES430416A ES430416A ES430416A1 ES 430416 A1 ES430416 A1 ES 430416A1 ES 430416 A ES430416 A ES 430416A ES 430416 A ES430416 A ES 430416A ES 430416 A1 ES430416 A1 ES 430416A1
Authority
ES
Spain
Prior art keywords
carbon atoms
formula
compound
see formula
ligation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES430416A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Corp SRL
Original Assignee
Pfizer Corp Belgium
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Corp SRL filed Critical Pfizer Corp Belgium
Publication of ES430416A1 publication Critical patent/ES430416A1/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/34—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5407—Acyclic saturated phosphonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)

Abstract

Procedure for preparing prostaglandin derivatives of the formula: **(See formula)** wherein: R is an alkanoyl having 2 to 8 carbon atoms or a cycloalkanoyl having 4 to 8 carbon atoms; aryl or a substituted aryl that has 7 to 11 carbon atoms in which the substituent is methyl, halogen, or methoxy; an alkylsulfonyl having 1 to 7 carbon atoms; heteroarylsulfonyl, arylsulfonyl, or substituted arylsulfonyl in which the substituent is methyl, halogen, or methoxy; R1 is hydrogen or an alkyl having 1 to 3 carbon atoms; it is an alkyl having 5 to 11 carbon atoms; W is a single tie or a double cis tie; Z is a single ligation or a double trans ligation: N is keto, (see formula); and THP is 2-tetrahydropyranyl, characterized in that a compound of the formula is reacted: **(See formula)** in which: R1, and R2 represent what is indicated above, with an ilide of formula: **(See formula)** in which: R represents what is indicated above and, when required, subsequently reducing said compound to produce a compound in which R, R1, R2 and Z represent what is indicated before and W is a simple ligation. (Machine-translation by Google Translate, not legally binding)
ES430416A 1972-06-07 1974-09-26 N-substituted prostaglandin carboxamides Expired ES430416A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26051872A 1972-06-07 1972-06-07

Publications (1)

Publication Number Publication Date
ES430416A1 true ES430416A1 (en) 1976-10-16

Family

ID=22989486

Family Applications (3)

Application Number Title Priority Date Filing Date
ES415611A Expired ES415611A1 (en) 1972-06-07 1973-06-06 N-substituted prostaglandin carboxamides
ES430416A Expired ES430416A1 (en) 1972-06-07 1974-09-26 N-substituted prostaglandin carboxamides
ES430417A Expired ES430417A1 (en) 1972-06-07 1974-09-26 N-substituted prostaglandin carboxamides

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES415611A Expired ES415611A1 (en) 1972-06-07 1973-06-06 N-substituted prostaglandin carboxamides

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES430417A Expired ES430417A1 (en) 1972-06-07 1974-09-26 N-substituted prostaglandin carboxamides

Country Status (24)

Country Link
JP (2) JPS5715591B2 (en)
AR (1) AR207434A1 (en)
AT (1) AT340069B (en)
BE (1) BE800580A (en)
CA (1) CA985280A (en)
CH (3) CH591511A5 (en)
CS (1) CS200166B2 (en)
DD (2) DD109211A5 (en)
DE (1) DE2329092A1 (en)
ES (3) ES415611A1 (en)
FI (1) FI58327C (en)
FR (2) FR2187344B1 (en)
GB (2) GB1439511A (en)
HU (3) HU170491B (en)
IE (1) IE38058B1 (en)
IL (2) IL42385A (en)
IN (1) IN138966B (en)
LU (1) LU67754A1 (en)
NL (2) NL160814C (en)
NO (2) NO146538C (en)
PH (2) PH14204A (en)
SE (3) SE415883B (en)
YU (1) YU36498B (en)
ZA (1) ZA733763B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX3291E (en) * 1975-04-23 1980-08-22 Upjohn Co PROCEDURE FOR PREPARING ANALOGS OF PROSTAGLANDINAS
US6395787B1 (en) 2000-02-08 2002-05-28 Allergan Sales, Inc. Ocular hypotensive lipids
US6476064B1 (en) * 2001-06-13 2002-11-05 Allergan, Inc. Cyclopentane heptan(ene) acyl sulfonamide, 2-alkyl or 2-arylalkyl, or 2-heteroarylalkenyl derivatives as therapeutic agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3187043A (en) * 1962-05-18 1965-06-01 Monsanto Co Monohalophosphonium halides

Also Published As

Publication number Publication date
JPS5715591B2 (en) 1982-03-31
PH14204A (en) 1981-04-01
IL42385A (en) 1979-10-31
NL160814B (en) 1979-07-16
NO740850L (en) 1973-12-10
NO146538C (en) 1982-10-20
FR2273814A1 (en) 1976-01-02
IL42385A0 (en) 1973-07-30
SE415883B (en) 1980-11-10
CA985280A (en) 1976-03-09
FI58327C (en) 1981-01-12
IL51525A0 (en) 1977-04-29
JPS4954350A (en) 1974-05-27
ATA504873A (en) 1977-03-15
ZA733763B (en) 1974-04-24
CH605887A5 (en) 1978-10-13
FR2187344B1 (en) 1977-10-28
LU67754A1 (en) 1973-12-14
AT340069B (en) 1977-11-25
DE2329092A1 (en) 1974-01-03
ES430417A1 (en) 1977-03-01
NL160814C (en) 1979-12-17
ES415611A1 (en) 1976-07-16
SE7608225L (en) 1976-07-19
NO142784C (en) 1980-10-15
IE38058L (en) 1973-12-07
IN138966B (en) 1976-04-17
BE800580A (en) 1973-12-07
AR207434A1 (en) 1976-10-08
NO142784B (en) 1980-07-07
NL7812163A (en) 1979-04-27
AU5643173A (en) 1974-12-05
FR2273814B1 (en) 1977-07-08
YU152673A (en) 1982-02-25
IE38058B1 (en) 1977-12-21
NO146538B (en) 1982-07-12
HU170487B (en) 1977-06-28
HU170491B (en) 1977-06-28
HU170200B (en) 1977-04-28
PH13092A (en) 1979-11-27
FR2187344A1 (en) 1974-01-18
CH591511A5 (en) 1977-09-30
SE418744B (en) 1981-06-22
DD115687A5 (en) 1975-10-12
DD109211A5 (en) 1974-10-20
YU36498B (en) 1984-02-29
NL7307867A (en) 1973-12-11
FI58327B (en) 1980-09-30
GB1439511A (en) 1976-06-16
JPS5731692A (en) 1982-02-20
SE7608224L (en) 1976-07-19
GB1439512A (en) 1976-06-16
CH593929A5 (en) 1977-12-30
CS200166B2 (en) 1980-08-29

Similar Documents

Publication Publication Date Title
ES394369A1 (en) Pharmacologically active 3-piperazinyl-carbonyloxy-2-pyridyl-isoindolin-1-ones
ES425900A1 (en) Animal feed containing 7-isopropoxy-isoflavone
ES413639A1 (en) Dopamine derivatives
ES401968A1 (en) Total steroid synthesis employing substituted isoxazole derivatives
ES430416A1 (en) N-substituted prostaglandin carboxamides
ES389360A1 (en) Aryloxy-and arylthioalkanoic acids and esters and salts thereof
ES404744A1 (en) Cephalosporin derivatives
ES398142A1 (en) 1-(p-benzamido)-3-methyl-triazenes
ES395766A1 (en) Procedure for the obtaining of derivatives of hidantoin. (Machine-translation by Google Translate, not legally binding)
ES321807A1 (en) Procedure for the synthesis of new derivatives of 1,2,3,6-tetrahidropiridina. (Machine-translation by Google Translate, not legally binding)
ES406768A1 (en) Procedure for the preparation of new indol derivatives. (Machine-translation by Google Translate, not legally binding)
ES413044A1 (en) Process for the preparation of cyanoalkyl substituted phenothiazi ne derivatives
ES364980A1 (en) A method for preparing new adamantan derivatives. (Machine-translation by Google Translate, not legally binding)
ES320083A1 (en) Procedure for the preparation of derivatives of difenylamine. (Machine-translation by Google Translate, not legally binding)
ES437041A1 (en) A procedure for preparing 1-ftalazone derivatives. (Machine-translation by Google Translate, not legally binding)
ES325448A1 (en) Procedure for producing 4-amino-5-halo-2-benzamide derivatives. (Machine-translation by Google Translate, not legally binding)
ES390275A1 (en) A procedure for the preparation of 1,2-dialquil (lower) pirrolydines. (Machine-translation by Google Translate, not legally binding)
ES441003A1 (en) Oxaprostaglandins
ES449429A1 (en) PROCEDURE TO PREPARE BENZOCICLOHEPTATIO-FENO DERIVATIVES.
ES392065A1 (en) A procedure for the preparation of a hydrazonium salt. (Machine-translation by Google Translate, not legally binding)
ES385679A1 (en) N-arylidene derivatives of erythromycylamine
ES325366A1 (en) PROCEDURE FOR THE PRODUCTION OF DERIVATIVES OF ISOQUINOLINE.
ES316075A1 (en) Procedure for the production of tropan derivatives. (Machine-translation by Google Translate, not legally binding)
ES383800A1 (en) Procedure for the obtaining of pyrimidine derivatives. (Machine-translation by Google Translate, not legally binding)
ES395875A1 (en) A procedure for the preparation of indol derivatives. (Machine-translation by Google Translate, not legally binding)